Rapid diagnostic kits are screening tools and have limitations (sensitivity/specificity vary by stage of illness and sample type). Positive or negative results should be interpreted alongside clinical findings and, if necessary, confirmed with laboratory-based assays (PCR/ELISA) according to local public health protocols. Always verify regulatory approvals and certificates with the supplier and follow biosafety and waste-disposal procedures when handling clinical specimens.
Abbott Dengue Duo (D) Alere Rapid Card — Product Description
Abbott Dengue Duo (D) Alere Rapid Card (pack of 10 tests) is a rapid diagnostic kit intended to assist in the detection of dengue infection by identifying both Dengue NS1 antigen and Dengue IgM/IgG antibodies from human blood samples. The test is suitable for early diagnosis and surveillance, helping healthcare providers quickly identify likely dengue cases for timely clinical decisions and outbreak control.
Designed for ease of use at the point of care, the Dengue Duo Rapid Card combines antigen (NS1) detection for early infection with antibody (IgM/IgG) detection to aid diagnosis across different stages of infection. This makes the kit useful for clinical settings, screening, and field surveillance where rapid results are required (always follow local diagnostic algorithms).
Key Features :
- Dual-marker detection: Dengue NS1 Antigen + Dengue IgM/IgG Antibodies on a single rapid card.
- Pack of 10 tests — convenient for clinics, screening teams, and surveillance use.
- Rapid, point-of-care format — designed for quick visual interpretation (refer to IFU for exact read time).
- Suitable for whole blood, serum, or plasma samples (confirm sample types in the IFU).
- Compact, easy-to-use cards — intended to support early diagnosis and epidemiological surveillance.
Note: Rapid tests are screening tools. Confirmatory testing (e.g., laboratory-based PCR or serology) and clinical correlation are recommended according to local guidelines. Always follow the manufacturer's instructions for use (IFU) and local regulatory requirements.

